Popova G M, Promyslov M Sh
Zh Vopr Neirokhir Im N N Burdenko. 2000 Jan-Mar(1):24-7.
The results of studies of the blood levels of lipid-bound sialic acids (LBSA) in patients with various brain tumors, subarachnoidal hemorrhage (SAH) caused arterial aneurysmal rupture and in those with brain injury (BI) are analyzed. Significant differences were found in blood LBSA levels in patients with hemispheric tumors and in those with chiasmal sellar ones. The findings suggest that blood LBSA levels cannot be a marker for brain tumors as the blood of patients with benign chiasmal sellar tumors shows high LBSA levels reaching those in patients with malignant hemispheric tumors. The blood levels of LBSA in patients SAH and BI were much higher than those in controls. The blood levels of LBSA are very equal in SAH and BI.
分析了各类脑肿瘤患者、由动脉瘤破裂引起的蛛网膜下腔出血(SAH)患者以及脑损伤(BI)患者的脂质结合唾液酸(LBSA)血水平研究结果。发现半球肿瘤患者和蝶鞍交叉部肿瘤患者的血LBSA水平存在显著差异。研究结果表明,血LBSA水平不能作为脑肿瘤的标志物,因为良性蝶鞍交叉部肿瘤患者的血液中LBSA水平很高,达到了恶性半球肿瘤患者的水平。SAH和BI患者的血LBSA水平远高于对照组。SAH和BI患者的血LBSA水平非常相近。